Table 1 Partial results of heterogeneity test.
From: Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis
Exposure | Gene/Protein | Outcome | p (Heterogeneity test) |
|---|---|---|---|
prot-a-1051 | FAM3D | Lung cancer || id:ieu-a-987 | 0.410077849 |
prot-a-1178 | GBP6 | Lung cancer || id:ieu-a-987 | 0.543732012 |
prot-a-1250 | GPD1L | Lung cancer || id:ieu-a-987 | 0.626766474 |
prot-a-1443 | IGF1 | Lung cancer || id:ieu-a-987 | 0.293745538 |
prot-a-1453 | IGFL3 | Lung cancer || id:ieu-a-987 | 0.725092934 |
prot-a-1526 | IL36A | Lung cancer || id:ieu-a-987 | 0.391123723 |
prot-a-1639 | KIN | Lung cancer || id:ieu-a-987 | 0.231946636 |
prot-a-1665 | KLK6 | Lung cancer || id:ieu-a-987 | 0.563646804 |
prot-a-1906 | MLN | Lung cancer || id:ieu-a-987 | 0.363953633 |
prot-a-2018 | NDC80 | Lung cancer || id:ieu-a-987 | 0.37346816 |
